Anthracycline-induced cardiotoxicity in children and young adults
Open Access
- 1 January 1998
- journal article
- review article
- Published by Elsevier BV in Critical Reviews in Oncology/Hematology
- Vol. 27 (1), 53-68
- https://doi.org/10.1016/s1040-8428(97)10007-5
Abstract
No abstract availableThis publication has 83 references indexed in Scilit:
- Cardiac transplantation in childhood cancer survivors in Great BritainEuropean Journal Of Cancer, 1996
- Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathyThe Lancet, 1996
- Myocardial function in children and adolescents after therapy with anthracyclines and chest irradiationEuropean Journal Of Cancer, 1996
- Assessment of anthracycline-related myocardial adrenergic derangement by [123i]metaiodobenzylguanidine scintigraphyEuropean Journal Of Cancer, 1995
- Limitations of fractional shortening as an index of contractility in pediatric patients infected with human immunodeficiency virusThe Journal of Pediatrics, 1994
- Cardioprotection by ICRF187 against high dose anthracycline toxicity in children with malignant disease.Heart, 1993
- Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast CancerNew England Journal of Medicine, 1988
- Clinical and morphologic cardiac findings after anthracycline chemotherapyThe American Journal of Cardiology, 1983
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977
- Revised standards for triceps and subscapular skinfolds in British children.Archives of Disease in Childhood, 1975